A comparative study of PENTA(TM) vaccine booster doses given at 12, 15 or 18 months of age

Vaccine

Volumn 17, Issue 6, 1999, Pages 543-550

  Scheifele, David W ^a   Guasparini, Roland ^b   Lavigne, Pierre ^c  

^a BC CHILDREN S HOSPITAL   (Canada)

^b Boundary Health Unit   (Canada)

^c Pasteur Merieux Connaught Canada   (Canada)

Author keywords

Childhood; Haemophilus influenzae; Immunization

Indexed keywords

ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; PARACETAMOL; PENTA; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; INFANT; INJECTION SITE; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABILITY; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

AGE FACTORS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; POLIOVIRUS VACCINE, INACTIVATED; POLYSACCHARIDES; RUBELLA VACCINE; TETANUS TOXOID; VACCINES, COMBINED;

EID: 0033547995     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00232-1     Document Type: Article

References (34)

1. Immunization Monitoring Program, Active (IMPACT) of the Canadian Pediatric Society and the Laboratory Center for Disease Control Recent trends in pediatric Haemophilus influenzae type b infections in Canada. Can Med Assoc J. 154:1996;1041-1047.
2. Haemophilus influenzae study group, Adams W.G., Deaver K.A., Cochi S.L., Plikaytis B.D., Zell E.R., Broome C.V., Wenger J.D. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 269:1993;221-226.
3. Peltola H., Kelpi T., Antilla M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet. 340:1992;592-594.
4. Van Alphen L., Spanjaard L., van der Ende A., Dankert J. Predicted disappearance of Haemophilus influenzae type b meningitis in Netherlands. Lancet. 344:1994;195. letter.
5. Kayhty H., Peltola H., Karanko V., Makela P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 147:1983;1100.
6. Robbins J.B., Parke J.C., Schneerson R., Whisnant J.K. Quantitative measurement of 'natural' and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res. 7:1973;103-110.
7. Ambrosino D., Schreiber J.R., Daum R.S., Siber G.R. Efficacy of human hyperimmune globulin in the prevention of Haemophilus influenzae type b disease in infant rats. Infect Immun. 39:1983;709-714.
8. Siber G.R., Thompson C., Reid G.R., Almeido-Hill J., Zacher B., Wolff M., Santosham M. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J Infect Dis. 165(supp 1):1992;S129-S133.
9. Granoff D.M., Holmes S.J. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines. Vaccine. 9(Supp):1991;530-534.
10. Decker M.D., Edwards K.M., Bradley R., Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr. 120:1992;184-189.
11. Scheifele D.W., Law B., Mitchell L., Ochnio J. Study of booster doses of two Haemophilus influenzae type b conjugate vaccines including their interchangeability. Vaccine. 14:1996;1399-1406.
12. Scheifele D.W., Meekison W., Guasparini R., Roberts A., Barreto L., Thipphawong J., Wiltsey S. Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine. 13:1995;104-108.
13. Santosham M., Hill J., Wolff M., Reid R., Lukacs L., Ahonkhai V. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatr Infect Dis J. 10:1991;113-117.
14. Decker M., Edwards K., Bradley R., Palmer P. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type b vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid. J Pediatr. 122:1993;410-413.
15. Dagan R., Botujansky C., Watemberg N., Arbelli Y., Belmaker I., Ethevenaux C., Fritzell B. Safety and immunogenicity in young infants of Haemophilus influenzae type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine. Pediatr Infect Dis J. 13:1994;356-361.
16. Kurikka S., Kayhty H., Saarinen L., Ronnberg P.R., Eskola J., Makela P.H. Comparisons of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. J Pediatr. 128:1996;524-530.
17. Immunization Practices Advisory Committee Haemophilus influenzae type b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Morb Mort Wk Rep. 40:1991;1-7.
18. Committee on Infectious Diseases, American Academy of Pediatrics Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: Update. Pediatrics. 88:1991;169-173.
19. National Advisory Committee on Immunization, Health Canada Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. Can Commun Dis Rep. 18:1992;169-176.
20. National Advisory Committee on Immunization, Health Canada Supplementary statement on newly licensed Haemophilus influenzae type b conjugate vaccines in combination with other vaccines recommended for infants. Can Commun Dis Rep. 20:1994;157-160.
21. Fritzell B., Plotkin S. Efficacy and safety of a Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine. J Pediatr. 121:1992;355-362.
22. National Advisory Committee on Immunization. Canadian Immunization Guide, 4th ed. Ottawa: Health Canada, 1993.
23. Maclennan R., Levine L., Nevell K.W., Edsall G. The early primary immune response to adsorbed tetanus toxoid in man. Bull Wld Hlth Org. 49:1973;615-626.
24. Granoff D.M., Holmes S.J., Osterblom M.T., McHugh J.E., Lucas A.H., Anderson E.L., Belshe R.B., Jacobs J.L., Medley F., Murphy T.V. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis. 18:1993;663-671.
25. Claesson B.A., Trollfors B., Lagergard T., Taranger J., Bryla D., Otterman G., Cramton T., Yang Y., Reimer D., Robbins J.B., Schneerson R. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J Pediatr. 112:1988;695-702.
26. Pasteur Mérieux Connaught, data on file.
27. Ipp M.M., Gold R., Goldbach M., Maresky D.C., Saunders N., Greenberg S., Davy T. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length. Pediatrics. 83:1989;679-682.
28. Ipp M., Gold R., Greenberg S., Golbach M., Kupfert B.B., Lloyd D.D., Maresky D.C., Saunders N., Wise S.A. Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. Pediatr Infect Dis J. 6:1987;721-725.
29. King G., Hadler S.C. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J. 13:1994;394-407.
30. Deforest A., Long S.S., Lischner H.W., Girone J.A.C., Clark J.L., Srinivasan R., Maguire T.G., Diamond S.A., Schiller R.P., Rothstein E.P., Schlackman N., Hipp T.J., Souder R.L., Bernier R.H. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines. Pediatrics. 81:1988;237-246.
31. McBean A.M., Gateff C., Manclark C.R., Foster S.O. Simultaneous administation of live attenuated measles vaccine with DTP vaccine. Pediatrics. 62:1978;288-293.
32. US Public Health Service Recommended childhood immunization schedule - United States, 1995. Morb Mort Wkly Rep. 44:1995;1-9.
33. Sprent J., Tough D.F. Lymphocyte life-span and memory. Science. 265:1994;1395-1400.
34. Zell E.R., Dietz V., Stevenson J., Cochi S., Bruce R.H. Low vaccination levels of US preschool and school-age children. JAMA. 271:1994;833-839.